pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 12·1 min read
save

FDA Commissioner Marty Makary resigns amid internal turmoil, top food regulator Kyle Diamantas to serve as acting chief

May 12, 2026·read at STAT ↗RegulatoryNegative

Food and Drug Administration Commissioner Marty Makary is leaving his post after serving a little over a year, according to an administration source. His tenure was marked by staff departures and internal disputes.

Sources said a faction within Health and Human Services had been dissatisfied with Makary’s leadership and had explored ways to remove him for months. Reports in the Wall Street Journal and other outlets suggested the White House was considering his dismissal, heightening speculation about his exit.

Kyle Diamantas, the agency’s senior official for food regulation, will assume the role of acting commissioner. Neither the White House nor representatives for Makary or HHS Secretary Robert F. Kennedy Jr. responded to requests for comment.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in”

read at STAT ↗
477 words · retrieved May 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Ultragenyx Pharmaceutical Inc.2ASTELLAS
drugs
Rare Disease2
topics
Rare Disease2Gene Therapy (AAV)

related stories

  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • Aug 13PTC takes a chance on Sangamo’s Fabry disease gene therapyBioPharma Dive
  • Aug 13Bankrupt Sangamo offloads assets to Lilly, PTC in $161M saleBioSpace
  • May 15STAT+: Top U.S. officials pressured Germany to pay more for prescription drugsSTAT
  • May 13STAT+: Drug meant to make gene therapy safer may also make it less effectiveSTAT